{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-008340","form_type":"8-K","ticker":"IONS","cik":"0000874015","company_name":"IONIS PHARMACEUTICALS INC","filed_at":"2026-03-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.871539+00:00","generated_at":"2026-05-15T18:26:16.410866+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Ionis announces retirement of two long-serving directors and appointment of Peter Reikes to board","bullets":["B. Lynne Parshall and Joseph Wender retiring at end of term in June 2026 after 25+ years on the board.","Peter N. Reikes to rejoin board effective June 4, 2026; he previously served from 2018-2021.","Reikes most recently senior strategy advisor for ARPA-H and senior advisor to FDA.","Both departing directors received Ionis Career Achievement Award; company thanks them."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-008340","json":"https://secwatch.observer/filing/0001140361-26-008340.json","markdown":"https://secwatch.observer/filing/0001140361-26-008340.md","text":"https://secwatch.observer/filing/0001140361-26-008340.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/874015/000114036126008340/0001140361-26-008340-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874015/000114036126008340/ef20067398_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T18:26:16.410866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}